These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1997015)

  • 21. Digoxin toxicity treated with Digibind.
    Schakenbach L; Arft P
    Crit Care Nurse; 1989 May; 9(5):16-22. PubMed ID: 2805742
    [No Abstract]   [Full Text] [Related]  

  • 22. Digitalis toxicity: mechanisms, diagnosis, and management.
    Bhatia SJ; Smith TW
    J Card Surg; 1987 Dec; 2(4):453-65. PubMed ID: 2979993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute massive digoxin overdose: survival without use of digitalis-specific antibodies.
    Springer M; Olson KR; Feaster W
    Am J Emerg Med; 1986 Jul; 4(4):364-8. PubMed ID: 3718631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential pharmacokinetics of digoxin in elderly patients.
    Hanratty CG; McGlinchey P; Johnston GD; Passmore AP
    Drugs Aging; 2000 Nov; 17(5):353-62. PubMed ID: 11190416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fab fragments in the treatment of digoxin overdose: pediatric considerations.
    Fazio A
    South Med J; 1987 Dec; 80(12):1553-6. PubMed ID: 2892273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related differences in digoxin toxicity and its treatment.
    Wells TG; Young RA; Kearns GL
    Drug Saf; 1992; 7(2):135-51. PubMed ID: 1605899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digoxin-specific antibody fragments: how much and when?
    Bateman DN
    Toxicol Rev; 2004; 23(3):135-43. PubMed ID: 15862081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical use of Digibind in digitalis toxicity.
    Morgera RV
    R I Med J (1976); 1991 Mar; 74(3):117-9. PubMed ID: 2038646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe poisoning with digitalis treated by the administration of anti-digoxin antibodies].
    Delgado Jiménez JF; Casillas Villamor A; Gómez Pajuelo C; Sáenz de la Calzada C
    Rev Clin Esp; 1991 Nov; 189(8):374-6. PubMed ID: 1784800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition and management of digitalis toxicity.
    Kelly RA; Smith TW
    Am J Cardiol; 1992 Jun; 69(18):108G-118G; disc. 118G-119G. PubMed ID: 1626485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study.
    Hickey AR; Wenger TL; Carpenter VP; Tilson HH; Hlatky MA; Furberg CD; Kirkpatrick CH; Strauss HC; Smith TW
    J Am Coll Cardiol; 1991 Mar; 17(3):590-8. PubMed ID: 1993775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
    Ujhelyi MR; Robert S
    Clin Pharmacokinet; 1995 Jun; 28(6):483-93. PubMed ID: 7656506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case series of hospitalized patients with elevated digoxin levels.
    Marik PE; Fromm L
    Am J Med; 1998 Aug; 105(2):110-5. PubMed ID: 9727817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of digoxin toxicity in outpatients.
    Steiner JF; Robbins LJ; Hammermeister KE; Roth SC; Hammond WS
    West J Med; 1994 Nov; 161(5):474-8. PubMed ID: 7810124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance.
    Zdunek M; Mitra A; Mokrzycki MH
    Am J Kidney Dis; 2000 Jul; 36(1):177-83. PubMed ID: 10873888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical aspects of severe digitalis poisoning and its treatment with and without digoxin-specific antibodies. 3 case reports].
    Haefeli WE; Ritz RF
    Schweiz Med Wochenschr; 1990 Feb; 120(6):155-8. PubMed ID: 2305225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Digoxin poisoning treated with Digibind].
    Andersen JB; Sørensen BU; Andersen LI
    Ugeskr Laeger; 1996 Apr; 158(16):2262-4. PubMed ID: 8650801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digoxin toxicity in the aged. Characterising and avoiding the problem.
    Passmore AP; Johnston GD
    Drugs Aging; 1991; 1(5):364-79. PubMed ID: 1794026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
    Antman EM; Wenger TL; Butler VP; Haber E; Smith TW
    Circulation; 1990 Jun; 81(6):1744-52. PubMed ID: 2188752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and successful management of suicidal digoxin toxicity without use of digoxin-specific antibody (Fab) fragments--is it possible?
    Sanaei-Zadeh H; Valian Z; Zamani N; Farajidana H; Mostafazadeh B
    Trop Doct; 2011 Apr; 41(2):108-10. PubMed ID: 21262953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.